Showcase Your Work
Join this informal session designed to help you connect with peers in a relaxed and collaborative environment while exploring the latest advances in model-informed approaches. With an audience of clinical and quantitative pharmacologists, pharmacologists, modelling and simulation experts who are eager to exchange ideas, this is your opportunity to present a poster showcasing your latest research, technologies or methodologies.
Don’t miss the chance to share your work, gain valuable feedback and spark new collaborations.
Why Present a Poster?
- Showcase your research and thought leadership in model-informed drug development
- Gain visibility among leading biopharma, biotech and regulatory experts working across pharmacometrics and quantitative sciences
- Engage in meaningful discussions with peers and receive direct feedback on your work
- Connect with potential collaborators and industry partners working across pharmacometrics, PBPK, QSP and clinical pharmacology
How to Submit Your Poster
- You must first register your place to attend the 2nd MIDD Summit
- Submit an abstract for review to showcase your poster during the Scientific Poster Session
- You will be notified once your abstract has been accepted along with details of printing and size requirements. We do request an online PDF of the poster 2 weeks prior to the summit
- Scientific Poster Session: November 18, 2026
- Abstract Submission Deadline: November 4, 2026
Click the 'Submit Your Poster' button below.
Please note, there is no additional charge, but you must be attending the conference to submit an abstract. Posters should not be used for sales and marketing purposes. All abstracts are subject to approval by the conference organizers, who reserve the right to reject submissions.
Explore the 2026 Full Event Guide
- Expert Speakers from Your Peers at Big Pharma, Emerging Biotechs & Regulatory Agencie
- Hands-On Workshops Covering AI Integration and Package Submission Readiness
- Case Studies Spanning Oncology, Autoimmune, Cell and Gene Therapy and Beyond
- Direct Regulatory Insight From the U.S FDA and Health Canada Perspectives
